Bloodstream Infections in Hematologic Malignancy Patients With Fever and Neutropenia: Are Empirical Antibiotic Therapies in the United States Still Effective?

BACKGROUND: Rising antimicrobial resistance rates may impact the efficacy of empirical antibiotic treatment for febrile neutropenia in high-risk cancer patients. Lacking contemporary data about the epidemiology, antibiotic resistance patterns, and clinical outcomes from bloodstream infections (BSIs)...

Descripción completa

Detalles Bibliográficos
Autores principales: Zimmer, Andrea J, Stohs, Erica, Meza, Jane, Arnold, Christopher, Baddley, John W, Chandrasekar, Pranatharthi, El Boghdadly, Zeinab, Gomez, Carlos A, Maziarz, Eileen K, Montoya, Jose G, Pergam, Steven, Rolston, Kenneth V, Satlin, Michael J, Satyanarayana, Gowri, Shoham, Shmuel, Strasfeld, Lynne, Taplitz, Randy, Walsh, Thomas J, Young, Jo-Anne H, Zhang, Yuning, Freifeld, Alison G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277632/
https://www.ncbi.nlm.nih.gov/pubmed/35854988
http://dx.doi.org/10.1093/ofid/ofac240

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277632/
https://www.ncbi.nlm.nih.gov/pubmed/35854988
http://dx.doi.org/10.1093/ofid/ofac240

Ejemplares similares